Vaxxinity Stock Price To Sales
| VAXXDelisted Stock | USD 2.72 0.19 6.53% |
Vaxxinity fundamentals help investors to digest information that contributes to Vaxxinity's financial success or failures. It also enables traders to predict the movement of Vaxxinity Pink Sheet. The fundamental analysis module provides a way to measure Vaxxinity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaxxinity pink sheet.
Vaxxinity |
Vaxxinity Company Price To Sales Analysis
Vaxxinity's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Vaxxinity Price To Sales | 4,605 X |
Most of Vaxxinity's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vaxxinity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Vaxxinity has a Price To Sales of 4.6 K times. This is much higher than that of the Biotechnology sector and notably higher than that of the Health Care industry. The price to sales for all United States stocks is notably lower than that of the firm.
Vaxxinity Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vaxxinity's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vaxxinity could also be used in its relative valuation, which is a method of valuing Vaxxinity by comparing valuation metrics of similar companies.Vaxxinity is currently under evaluation in price to sales category among its peers.
Vaxxinity Fundamentals
| Return On Equity | -1.51 | ||||
| Return On Asset | -0.48 | ||||
| Current Valuation | (1.39 M) | ||||
| Shares Outstanding | 112.91 M | ||||
| Shares Owned By Insiders | 50.90 % | ||||
| Shares Owned By Institutions | 12.24 % | ||||
| Number Of Shares Shorted | 4.22 M | ||||
| Price To Book | 4.58 X | ||||
| Price To Sales | 4,605 X | ||||
| Gross Profit | (1.87 M) | ||||
| EBITDA | (56.05 M) | ||||
| Net Income | (56.93 M) | ||||
| Cash And Equivalents | 128.23 M | ||||
| Cash Per Share | 1.02 X | ||||
| Total Debt | 15.17 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 5.46 X | ||||
| Book Value Per Share | 0.11 X | ||||
| Cash Flow From Operations | (57.24 M) | ||||
| Short Ratio | 13.97 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Price To Earnings To Growth | 0.05 X | ||||
| Target Price | 15.0 | ||||
| Number Of Employees | 57 | ||||
| Beta | 2.4 | ||||
| Market Capitalization | 14.09 M | ||||
| Total Asset | 44.35 M | ||||
| Retained Earnings | (361.64 M) | ||||
| Working Capital | 15.62 M | ||||
| Net Asset | 44.35 M |
About Vaxxinity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vaxxinity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxxinity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxxinity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Vaxxinity Pink Sheet
If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |